Jiangbo Pharmaceuticals (ehem. GNPH) - A0RNJB/JGBO
http://www.jiangbopharma.com/....php?fir_lineid=74&sec_lineid=479
| |
| |
|
Received Certificates of Good Manufacturing Practices for
In China muss man alle 5 Jahre eine Rezertifizierung der Produktionsstätten durchlaufen.
Gültig weitere 5 Jahre bis 24.11.2014 !
Deshalb der Umsatzeinbruch im letzten Quartal (6 Wochen Rezertifizíerung) , Produktionsmaschinen laufen wieder...gutes Quartal sollte kommen !! :-)
Ich baller nochmal nach...
Top Chinese Companies to Present at China Rising Investment Conference
NEW YORK, May 4 /PRNewswire-Asia/ -- CCG Investor Relations, a leading global investor relations and strategic communications agency, today announced that approximately 40 U.S.-listed Chinese companies will present at the China Rising Investment Conference at New York City's Grand Hyatt on May 17.
"China's return to robust GDP growth and increased domestic consumption has created opportunities to invest in outstanding companies in what continues to be the fastest growing major economy in the world," said Crocker Coulson, President of CCG Investor Relations.
"This year's China Rising Conference offers investors the chance to meet with senior management of high growth public and private enterprises in industries spanning infrastructure, technology, consumer, healthcare, tourism, agriculture, and alternative energy, all of which are highly promising sectors in China today."
Some of the participating companies include:
Asia Bio-Chem Group Corp. (ABC.V)
Asia Pacific Wire & Cable Corporation (AWRCF.OB)
Beijing Teamspirit Advertising Co., Ltd.
China BAK Battery ( CBAK)
China BuildTech Co.
China Clean Energy, Inc (CCGY.OB)
China Gerui Advanced Materials ( CHOP)
China Industrial Waste Management, Inc (CIWT.OB)
China New Energy Group Company (CNER.OB)
China Sky One Medical, Inc ( CSKI)
China Skyrise Digital Service, Inc (CSKD.OB)
China TransInfo Technology Corp ( CTFO)
China XD Plastics ( CXDC)
China Yida Holding, Co ( CNYD)
e-Future Information Technology Inc. ( EFUT)
FINET Group (HKSE: 8317.HK)
Gulf Resources, Inc ( GFRE)
Hengfeng Shoes & Garment Co., Ltd
Jiangbo Pharmaceuticals, Inc. (JGBO.OB)
Jinpan International Ltd ( JST)
Jingwei International Limited (JNGW.OB)
Orient Paper Inc. (NYSE ONP)
Pansoft Company Ltd ( PSOF)
Puda Coal, Inc (NYSE PUDA)
Trunkbow International Holdings
Universal Travel Group ( UTA)
Wuhan General Group ( WUHN)
Yongye International Biotechnology, Inc. ( YONG)
Yuhe International, Inc ( YUII)
ZST Digital Networks, Inc. ( ZSTN)
The conference is free to attend for fund managers and institutional investors. List is subject to change.
Media Interviews available with select companies by request.
Sponsors of this year's conference include Anslow & Jaclin LLP, Bernstein & Pinchuk LLP, Brean Murray Carret & Co., Ladenburg Thalmann & Co, Loeb & Loeb LLP, Merriman & Co, Newbridge Securities, PR Newswire, Rodman & Renshaw LLC, Roth Capital Partners, The Crone Law Group and Westpark Capital.
For information about sponsorship opportunities contact: Crocker Coulson at +1-646-213-1915 or crocker.coulson@ccgir.com.
For media inquiries please contact: Mabel Zhang at mabel.zhang@ccgir.com or 310-9541353.
For Chinese companies interested in participating in the China Rising Investment Conference, please contact Diana Liu at diana.liu@ccgir.com or 646-833-3459. There is no charge to present.
Institutional investors interested in attending, please register at http://tinyurl.com/ChinaRisingRegistration .
For presentation schedule and other information on the conference, please visit http://www.chinarisingconference.com or contact events@ccgir.com.
About CCG Investor Relations:
CCG is a leading global investor relations and strategic communications consulting firm. In business for more than 30 years, the agency provides a complete range of investor communications, counseling, and IT and data solutions through our global network to over 300 clients across multiple capital markets. CCG has been awarded a number of industry honors for its handling of complex investor relations and crisis communications matters. The agency's corporate headquarters is in Los Angeles with additional offices in New York, Beijing, Shanghai, Hong Kong, Sydney, Frankfurt, Sao Paulo and Tel Aviv. For further information, contact CCG directly, or visit the Company's web sites at http://www.ccgir.com and http://www.ccgirasia.com .
SOURCE CCG Investor Relations
Back to top
RELATED LINKS
http://www.ccgir.com
http://www.ccgirasia.com
http://www.chinarisingconference.com
Optionen
| Boardmail an "datschi" |
Wertpapier: JIANGBO PHARMACEUTICALS |
http://ih.advfn.com/p.php?pid=nmona&article=42844553
Wirst schon sehen...gut Ding dauert eben...
GO TSCHANGBO !!! :-)
Wenn nur mal Volumen geht dann pfeift das Ding hier SENKRECHT nach oben sowas hast du noch NIE gesehen... :-)
KERX...grrrrrrrrrrrrrrrrr
Wer das wohl war...hmmm :-)
ax???
Was fehlt ist hier in 192 Posts beschrieben...
GO JIANGBO !!
Mit beiden Händen...kaufen was das Zeug hält...wir traden ca. Cash/Aktie !!!!!!!!
Das ist ein GESCHENK !!!
Working Capital pS 8.29 $ Cash pS 7.39 $ Book-Value pS 8.67 $
Und jetzt verrate ich keine Geheimnisse mehr muss nämlich jetzt erstmal weg.
Nicht vergessen unter 7€ mit BEIDEN HÄNDEN KRÄFTIG ZUSCHLAGEN !!! :-)
Es könnte sich nämlich durchaus lohnen.
Wenn die 10$ mal wieder durchbrochen sind ist sehr viel Luft nach oben !
3 Reports wurden abgeändert...(amended)
http://www.sec.gov/cgi-bin/...nd=Find+Companies&action=getcompany
Eventuell zwecks Anforderungen der SEC wg. Uplisting. (Also ich hab da noch grosse Hoffnungen gerade zu dem Schleuderpreis)
10-Q/A Documents [Amend]Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001144204-10-027207 (34 Act) Size: 1 MB 2010-05-14 000-53037
10831532
10-Q/A Documents [Amend]Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001144204-10-027204 (34 Act) Size: 1 MB 2010-05-14 000-53037
10831528
10-K/A Documents [Amend]Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0001144204-10-027200 (34 Act) Size: 1 MB 2010-05-14 000-53037
10831520
http://www.jiangbopharma.com/uploaded/